Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3851-3864
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Table 4 Monitoring of metabolic disease after liver transplantation
Metabolic disease | Monitoring indicator | Target | Other related examination items |
Diabetes mellitus | FPG, HbA1c, and OGTT | FPG < 6.7 mmol/L, peak value < 8.88 mmol/L or HbA1c < 7% | Urinary protein, ophthalmoscopy, B-mode ultrasonography of the carotid artery, and coronary CT angiography |
Hypertension | Arterial pressure | Arterial pressure < 130/80 mmHg | 24-h ambulatory blood pressure, ECG, coronary CT angiography, urinary protein, ophthalmoscopy |
Dyslipidemia | LDL-C, TC, TG | LDL-C < 100 mg/dL; patients with cardiovascular risk factors, LDL-C < 70 mg/dL | ECG, B-mode ultrasonography of the carotid artery and coronary CT angiography |
Hyperuricemia | SUA | SUA < 360 μmol/L; patients with gout attack, SUA < 300 μmol/L | Urinary protein, serum creatinine, glomerular filtration rate, bilateral renal ultrasound, joint ultrasound, joint X-ray or CT |
Obesity | BMI | BMI < 25 kg/m2 | Coronary CT angiography and B-mode ultrasonography of the carotid artery |
- Citation: Shen T, Zhuang L, Sun XD, Qi XS, Wang ZH, Li RD, Chang WX, Yang JY, Yang Y, Zheng SS, Xu X. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol 2020; 26(27): 3851-3864
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3851